It's all about manipulation right now. They're posting a large ask in hopes that it will make people back off on the buying. Best case scenario for them maybe even scare some people into selling. If you notice, it is also CDEL who is leading the bid at .0021. It's all just a game.

CDEL trying to scare shares away from people. Start hitting that ask and he will disappear I bet.

Exactly! Everyone needs to read your post!

I think you are right. It could happen any day now. Although, if it takes until next week I won't be mad as I have more funds clearing ;)

I agree! The .0020 support level I talked about earlier held up. Also, VNDM has pulled back to .0027. So long as BKRT, VNDM, or VFIN don't show back up, we will close green today.

They can't announce a dividend date until the SEC approves the S-1/A they filed two days ago. It's not up to them. Once the SEC approves that, the date will be announced.

The key word is "cash" dividends. This is a stock dividend.

BKRT was gone for around the last hour of trading. If BKRT stays away I see a trading range of .0020-.0029. If this busts through the 200MA again it very well may breakout.

.0026 @ the 200MA will be the first resistance level that must be broken. .0030 will be a secondary resistance level.

.0020 will be the first key support level. .0017 will be the secondary key support level.

Here is the link to the SEC filings for BMSN and Regen BioPharma.

Educate yourselves people!

http://www.sec.gov/cgi-bin/browse-edgar?company=regen+biopharma&owner=exclude&action=getcompany

http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001079282&owner=exclude&count=40&hidefilings=0

Hahahahaha!!! Best post of the day.....perhaps sticky worthy LOL. Although I am glad with the attention we're getting since becoming a top breakout board and with the recent volume that the information is finally current.

Yes, orphan status comes with exclusivity rights for 7 years.

And that information I copied came straight from the FDA website.

http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/HowtoapplyforOrphanProductDesignation/ucm364750.htm

Even if they don't have a patent remember they are planning on receiving orphan drug status.

PROTECTION FOR UNPATENTED DRUGS FOR RARE DISEASES OR CONDITIONS
SEC. 527 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT [21 USC 360cc]. (a) Except as provided in subsection (b), if the Secretary---
(1) approves an application filed pursuant to section 505, or
(2) issues a license under section 351 of the Public Health Service Act

for a drug designated under section 526 for a rare disease or condition, the Secretary may not approve another application under section 505 or issue another license under section 351 of the Public Health Service Act for such drug for such disease or condition for a person who is not the holder of such approved application or of such license until the expiration seven years from the date of the approval of the approved application or the issuance of the license. Section 505(c)(2) does not apply to the refusal to approve an application under the preceding sentence.
(b) If an application filed pursuant to section 505(b) is approved for a drug designated under section 526 for a rare disease or condition, or if a license is issued under section 351 of the Public Health Service Act for such a drug, the Secretary may, during the seven-year period beginning on the date of the application approval, or of the issuance of the license, approve another application under section 505(b) or issue a license under section 351 of the Public Health Service Act, for such drug for such disease or condition for a person who is not the holder of such approved application or of such license if---
(1) the Secretary finds, after providing the holder notice and opportunity for the submission of views, that in such period the holder of the approved application, of the certification, or of the license cannot assure the availability of sufficient quantities of the drug to meet the needs of persons with the disease or condition for which the drug was designated; or
(2) such holder provides the Secretary in writing the consent of such holder for the approval of other applications, or the issuance of other licenses before the expiration of such seven-year period.

BKRT just backed off

This is interesting from the S-1/A from November.

Pursuant to a Service Agreement entered into by and between the Company and Dr. Wei-Ping Min , on Sept 24, 2013 the Company began experiments required to be undertaken in order to address the FDA’s comment concerning efficacy. Studies required to be undertaken in order to address the FDA’s comments concerning safety are anticipated to begin in December 2013. It is estimated by the Company that completion of efficacy studies will require 3 months, and the safety studies will be completed in 2 months

So they began the efficacy studies on 9/24/13 and said it'd take 3 months. They completed those studies and announced the results on 12/11/13 which was 13 days prior to 3 months. So they certainly buffered in some extra time within the timeline they gave us.

Taking that into consideration, the PR released on 12/11/13 states that the safety studies were already under way but doesn't specify the date they began them. The S-1/A filed in January says:

Studies required to be undertaken in order to address the FDA’s comments concerning safety commenced in December 2013

So if they began these tests the first week of December 2013, and they finished two weeks early like they did with the efficacy studies, that would mean they could be finished with all testing and submitted it to the FDA as early as this week!

Yes, we do know those numbers, they are all in the S-1/A.

A/S 500,000,000
O/S 51,910,000 (50,010,000 owned by BMSN)

The dividend is on 20,000,000 of those 50,010,000.

It's just a hit through searching for HemaXellerate on Google. It links to the FDA website six hours ago. It was posted earlier that it is indicative of updating within the FDA site's private catalogues. Nothing will be posted on the FDA website publicly until approval is announced publicly.

New hit for HemaXellerate on the FDA website 6 hours ago!!!

I know someone posted earlier about a hit, if that was the one you were speaking of I apologize. I'm not trying to steal anyone's thunder, just inform!

http://www.google.com/#q=hemaxellerate&safe=active&tbs=qdr:w

There are 6 different moderators and any one at any given time can choose to label something as off-topic. It's hard to have consistency with 6 different individuals who have different interpretations as to what that means. If you ever believe something you posted was removed in error, you have the ability to challenge that with the site Admin, so remember that.

The dividend is shares in Regen BioPharma, not BMSN. Which will only have 20,000,000 shares publicly traded. THAT, is a HUGE deal.

Give it some time, the shorts are still trying to keep it from flying up too much. If we close above the 200ma chartists all over OTC will come in tomorrow.

I did not say you were pumping. Simply noting that you usually are quite negative in regards to this stock.

And I was simply asking a question too which you did not answer. Are you still planning on relinquishing your moderator spot once BMSN hits .0041?

;)

Wow skipper, did you turn your ship around? ;)

Are you still planning on relinquishing your moderator spot once this hits .0041? ;)

BMSN!
Regen!

Around how long do you suspect it will be until we see the NOTICE OF EFFECTIVENESS for the S-1/A filed today?

Once again everyone, the S-1/A was filed today!!!

Likely to be put into effect this time!!!

Don't want to brag, but I did call it being filed within this date range ;) I predicted between 1/10 and 1/15

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=95647307

http://www.sec.gov/cgi-bin/browse-edgar?company=regen+biopharma&owner=exclude&action=getcompany

S-1/A filed today!!! That's what's going on!!!

http://www.sec.gov/cgi-bin/browse-edgar?company=regen+biopharma&owner=exclude&action=getcompany

They were required to run two sets of experiments per FDA request. They were announcing the completion of the first set of tests and the positive results. In that same PR they announced that they had already began the second set of tests that the FDA requested. According to the S-1/A this second set should take approximately 2 months to complete so they should be over halfway finished with them as of today.

If you look in the sticky notes there is a good description of the timeline and where we currently stand.

May see .0016 or .0017 today.

I think it's a good sign that the total current assets increased by $41,000 year over year and that the total current liabilities decreased $447,000 year over year. You can see that BMSN and Koos has been paying off debt which is great news.

Also, like some others have mentioned, they speak an awful lot about the regulatory process in Europe. This tells me they intend to seek approval in Europe as well as in the United States.

dCellVax Trademark approved for publication!!!

http://tsdr.uspto.gov/#caseNumber=86073736&caseType=SERIAL_NO&searchType=documentSearch

Simply click the status tab, then scroll down and click prosecution history.

The Lawson Health Research Institute where Dr. Min is a scientist knew how big of a deal his appointment to the board of Regen BioPharma was that they Tweeted about it!

Congrats to Wei-Ping Min, appointed to Scientific Advisory Board to accelerate development of stem cell therapeutics! http://t.co/swjv2LyN

— Lawson Health Research Institute (@lawsonresearch) June 7, 2012

Based on how long it took Regen BioPharma to submit the S-1/A following the submission of the original S-1, I would also expect to see a new S-1/A filed sometime between 1/10/14 and 1/15/14.

Hopefully this one will be approved by the SEC and placed into EFFECT!

Thanks and I'm glad to have done it. The information up there before was seriously outdated.

If anyone hasn't checked it out lately, or is new to BMSN/Regen BioPharma he/she should check out the information above on the intro page.

Further confirmation of Dr. Thomas Ichim's involvement with Regen BioPharma/BMSN

http://h1b-visas.findthecompany.com/l/90562/Regen-Biopharma-Inc-in-La-Mesa-CA-91942

CORRECTION....dCellVax USPTO status actually changed today! It was assigned to an examiner as of today. It's not updated on trademarkia yet but it is on the USPTO site if you dig deep enough.

Click the status tab on the left. Then scroll down and click the prosecution history tab.

http://tsdr.uspto.gov/#caseNumber=86073736&caseType=SERIAL_NO&searchType=documentSearch

The Trademark status for dCellVax should be updated fairly soon (probably the next week or two). It took HemaXellerate roughly 3 1/2 months to be updated in the USPTO system following its application. It will be 3 1/2 months from the dCellVax filing somewhere between January 8th-January 15th depending on how the holidays affect the timeline.

http://tsdr.uspto.gov/#caseNumber=85895235&caseType=SERIAL_NO&searchType=documentSearch

http://tsdr.uspto.gov/#caseNumber=86073736&caseType=SERIAL_NO&searchType=documentSearch

Thanks. No, I can't do anything to any board other than the BMSN board. You have to be a moderator to alter anything on the intro page and I'm not a moderator on that stock.

I've updated a ton of information on the intro page. If anyone sees anything that I've neglected to put up that you feel is pertinent to BMSN/Regen then just let me know and I will do what I can. Any serious comments and/or constructive criticism is welcome as well.

This is a fantastic article that explains what can happen when a stock that is being shorted issues a dividend. Sound familiar?

Also, take a look at their stock chart and how the price increases coincide with their dividend dates.

http://seekingalpha.com/article/1645772-biolase-ceo-takes-dead-aim-at-naked-short-sellers-main-street-cheers

Every company has a "Risk Factors" section within their filings just like Regen and BMSN do. This is standard procedure. Below is a link to a recent filing from Apple and even they have a "Risk Factors" section where they talk about all the negative possibilities that could happen to the company.

I'm pretty sure Apple isn't going away any time soon and neither is BMSN or Regen BioPharma!

http://www.sec.gov/Archives/edgar/data/320193/000119312513300670/d552802d10q.htm

Here is how to calculate how many shares of Regen BioPharma you will get per the dividend.

The dividend announced that they are issuing 20,000,000 shares of Regen BioPharma on a pro-rata basis to shareholders of BMSN common and preferred shares.

Below are the most recent numbers of each type of shares that are issued as per SEC filings:

Common: 2,810,513,321
Preferred: 1,963,821
AA: 94,852
AAA: 40,000
B: 725,409

So if you add together all of the common and various preferred shares it comes out to a total of 2,813,412,403 shares outstanding.

If you then divide the number of Regen shares to be distributed (20,000,000) by the total number of BMSN shares (2,813,412,403) you get .007108805. That is how many shares of Regen you get per share of BMSN that you own.

Simply multiply the number of BMSN shares you own by .007108805 and you get how many shares of Regen you will be given from the dividend.

Below are the FDA filings from which I pulled the numbers from.

http://www.sec.gov/Archives/edgar/data/1079282/000155479513000456/bmsn6302013form10q.htm

http://www.sec.gov/Archives/edgar/data/1079282/000155479513000765/bmsn12231310ka.htm

http://www.sec.gov/Archives/edgar/data/1589150/000155479513000724/regen112013forms1a.htm